Growth Metrics

Evolent Health (EVH) Long-Term Investments (2016 - 2026)

Evolent Health has reported Long-Term Investments over the past 12 years, most recently at $2.7 million for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 81.96% year-over-year to $2.7 million; the TTM value through Dec 2025 reached $2.7 million, down 81.96%, while the annual FY2025 figure was $2.7 million, 81.96% down from the prior year.
  • Long-Term Investments for Q4 2025 was $2.7 million at Evolent Health, up from $2.7 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $17.6 million in Q2 2023 and troughed at $2.7 million in Q3 2025.
  • A 5-year average of $10.7 million and a median of $12.6 million in 2021 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: soared 359.2% in 2023 and later crashed 81.96% in 2025.
  • Year by year, Long-Term Investments stood at $13.0 million in 2021, then dropped by 3.94% to $12.5 million in 2022, then surged by 35.28% to $16.9 million in 2023, then decreased by 11.06% to $15.0 million in 2024, then crashed by 81.96% to $2.7 million in 2025.
  • Business Quant data shows Long-Term Investments for EVH at $2.7 million in Q4 2025, $2.7 million in Q3 2025, and $9.0 million in Q2 2025.